We have studied the nature of Epstein-Barr virus (EBV) infection in 33 patients with chronic active EBV infection. The study population included 14 patients with fatal chronic EBV infection and 19 patients with nonfatal chronic EBV infection, as well as 18 patients with acute EBV-induced infectious mononucleosis and 10 healthy controls. EBV DNA was measured in serum or plasma samples from the patients by semiquantitative polymerase chain reaction -based assay. EBV DNA was detected in serum or plasma samples from 62% (9/14) of patients with fatal chronic active EBV infection. In contrast, only 11% (2/19) of patients with nonfatal chronic active EBV infection and 11% (2/18) of patients with infectious mononucleosis displayed EBV DNA. None of the healthy controls tested positive. Cell-free circulating EBV DNA may represent an important feature of chronic active EBV infection and may provide a useful tool to monitor the severity of this illness.
Epstein-Barr virus (EBV) is a causative agent of acute infec-
with chronic active infection, we sought to measure EBV DNA in serum or plasma from a group of 33 patients with chronic tious mononucleosis, a self-limited disorder characterized by fever, lymphadenopathy, hepatosplenomegaly, and the occuractive EBV infection of varying severity, including 14 with fatal infection. rence of atypical lymphocytes in the peripheral blood [1 -3] . Rarely, primary EBV infection is followed by persistent or recurrent infectious mononucleosis -like symptoms associated
Materials and Methods with an unusual pattern of anti-EBV antibodies, a poorly characterized syndrome identified as chronic active EBV infection
Study population. The study population (table 1) consisted [4] . Over the course of months or years, some patients with of 33 patients (22 male, 11 female), aged 1 -67 years, who cases of chronic active EBV infection develop life-threatening were diagnosed with chronic active EBV infection at Kochi complications, including T cell lymphoproliferative disease and Medical School Hospital on the basis of the criteria described pancytopenia [5, 6] .
elsewhere [4 -6] . Briefly, a diagnosis of chronic active EBV The presence of high-titer antibodies to EBV early antigens infection required chronic or recurrent infectious mononucleoand capsid antigen in patients with chronic active EBV infecsis -like symptoms lasting for at least 1 year, life-threatening tion suggested that increased EBV replication is a feature of conditions with lymphadenopathy and hepatosplenomegaly this illness. Recently, IL-10 was detected at abnormally high over the course of months or years, or both; an unusual pattern levels in serum or plasma of patients with chronic active EBV of antibodies to EBV with raised titers of antibody to early infection, further supporting the occurrence of enhanced viral antigen, absent antibodies to EBV nuclear antigen, or both; replication in this illness [7, 8] .
and no evidence of prior immune abnormalities or infections EBV is usually replicated in the oropharynx and is shed into to explain the condition. Plasma or serum samples were obthe saliva [1] . EBV DNA is also detectable in serum from tained from patients with informed consent and were cryoprea proportion of patients with acute EBV-induced infectious served at 070ЊC until testing. Patients with chronic active EBV mononucleosis, suggesting the occurrence of viremia [9] . To infection were divided into cases of nonfatal (n Å 19) and fatal gain further insight into the nature of EBV infection in patients infection (n Å 14). Causes of death ( NOTE. AIHA Å autoimmune hemolytic anemia; CMV Å cytomegalovirus; EBV Å Epstein-Barr virus; ITP Å idiopathic thrombocytopenic purpura; JCML Å juvenile chronic myelogenous leukemia; JRA Å juvenile rheumatoid arthritis; Mosq Å hypersensitivity to mosquite bite; NHL Å non-Hodgkin's lymphoma; VAHS Å virus-associated hemophagocytic syndrome. from the Namalwa cell line. The extracted DNA was placed 6% acrylamide Tris-borate-EDTA gels, followed by autoradiography and quantification. in 20 mL of Tris-EDTA solution. Primer pairs specific for a 134-bp region were generated from the BamHI-W region of Statistical analysis. Fisher's exact test was calculated by conventional formulas. the EBV genome described elsewhere [10] . The reaction mixture (25 mL) consisted of 2 mL of DNA solution (equivalent to 10 mL of plasma or serum samples, or 1 - The number of amplification cycles (31 cycles) was selected infectious mononucleosis, and 10 healthy controls were tested for the presence of EBV DNA. The sensitivity of the EBV to provide the maximum signal intensity within the linear part of a product-versus-template amplification curve. Aliquots DNA PCR-based detection assay was established by use of serial dilutions of DNA from the EBV-infected Namalwa cell from each amplification reaction were electrophoresed through / 9c64$$ap70 03-15-99 11:14:23 cida UC: CID Kanegane et al. CID 1999; 28 (April) EBV infection have EBV DNA in serum or plasma at a significantly greater frequency than do patients with nonfatal chronic active EBV infection (P Å .0019), patients with acute EBVinduced infectious mononucleosis (P Å .0025), or healthy controls (P Å .0015).
Discussion
The present study shows that 62% of patients with fatal chronic active EBV infection had detectable EBV DNA in serum or plasma, compared with 11% of patients with nonfatal chronic active EBV infection, 11% of patients with acute EBVinduced infectious mononucleosis, and none of the healthy adult controls expected to be EBV-seropositive.
Gan et al. [9] reported that 27% of patients with acute EBVinduced infectious mononucleosis and 10% of healthy EBV carriers displayed EBV DNA in serum. However, by use of an assay with a sensitivity of 10 3 EBV DNA copies/mL of plasma based on plasmid EBV DNA, Yamamoto et al. [10] reported that 100% of plasma samples from patients with acute EBVinduced infectious mononucleosis but none from the healthy controls displayed EBV DNA. In the same report [10] , all 4 patients with chronic active EBV infection of unspecified se- The current study on a large cohort of patients with chronic active EBV infection shows that a significantly greater proportion of patients with fatal disease (62%) have EBV DNA detectline, which is known to contain 1 or 2 copies of viral DNA per cell. By use of aliquots of Namalwa cell -derived DNA able in serum or plasma than do patients with nonfatal disease (11%) and that the positive samples from patients with fatal corresponding to 1 -10 5 cells, a positive signal was consistently derived from PCR amplification of 10 cell equivalents (figure disease contain higher EBV DNA levels than do those from patients with nonfatal infection. These results suggest that dis-1). This finding indicated that this assay could detect at least 10 copies of EBV DNA.
ease severity directly correlates with levels of EBV DNA in serum or plasma. Although we cannot exclude that cell-derived Using the Namalwa cell line as an internal standard for EBV DNA (corresponding to 1 -10 5 EBV DNA copies), we EBV DNA might be present in some of the serum or plasma samples analyzed here, it is unlikely that it might have selecmeasured EBV DNA in serum or plasma samples. Since test DNA was equivalent to 10 mL of serum or plasma, the tively contributed to the positive results in patients with fatal chronic active EBV infection, because these patients, unlike assay had the potential to detect at least 1,000 EBV DNA copies/mL of serum or plasma.
patients with acute EBV-induced infectious mononucleosis, generally display normal levels of EBV-infected cells in the EBV DNA was detected in serum or plasma samples from 62% (9/14) of patients with fatal chronic active EBV infection, circulation [11] . Thus, increased frequency and levels of EBV DNA in patients with severe chronic active EBV infection and the mean value for the 9 positive samples was 576,500 EBV DNA copies/mL. In contrast, only 11% (2/19) of serum could reflect the occurrence of increased EBV replication and subsequent viremia. In a recent report, T cell lymphoma tissues or plasma samples from patients with nonfatal chronic active EBV infection and 11% (2/18) of patients with acute EBVfrom two patients with chronic active EBV infection displayed evidence of BZLF-1 and BCRF-1 expression, consistent with induced infectious mononucleosis tested positive for EBV DNA. The numbers of EBV DNA copies per milliliter of serum the occurrence of EBV replication in these tissues [12] . The pathogenesis of chronic active EBV infection is not or plasma were 1,000 and 51,300 in the 2 patients with nonfatal chronic active EBV infection and 1,800 and 3,400 in the 2 clear, and the role EBV plays in this illness is uncertain. Recently, a number of studies have suggested that T cell infection patients with acute EBV-induced infectious mononucleosis. None of the healthy controls were found to have EBV DNA with EBV may be important to the pathogenesis of some severe cases of chronic active EBV infection [12 -14] . The finding in serum or plasma. Thus, patients with fatal chronic active / 9c64$$ap70 03-15-99 11:14:23 cida UC: CID
